Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients.

Slides:



Advertisements
Similar presentations
Update on Imaging: Detection of Iron in Liver and Heart Tim St. Pierre, BSc, PhD Professor School of Physics The University of Western Australia Crawley,
Advertisements

1 Rash and Low T2* MRI in a Paediatric Thalassaemia Patient.
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,
Kris V. Kowdley, Patricia Belt, Laura A. Wilson, Matthew M. Yeh, Brent A. Neuschwander-Tetri, Naga Chalasani, Arun J. Sanyal, and James E. Nelson ; for.
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Kamyar Kalantar-Zadeh  Kidney International 
by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
Navneet S. Majhail, Todd DeFor, Hillard M. Lazarus, Linda J. Burns 
by Jane S. Hankins, M. Beth McCarville, Ralf B. Loeffler, Matthew P
by Seth Rivera, Lide Liu, Elizabeta Nemeth, Victoria Gabayan, Ole E
by Toru Takahashi, Toshiaki Yujiri, and Yukio Tanizawa
by Khaled M. Musallam, Vijay G
Finding a diamond in the (mouse is) rough
Next-generation leukemia immunotherapy
Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis by Shameem Mahmood, Julie Blundell,
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic.
A Point-of-Care Paper-based Fingerstick Transaminase Test: Toward Low-cost “Lab-on- a-Chip” Technology for the Developing World  Nira R. Pollock, Donn.
Iron-Chelating Therapy and the Treatment of Thalassemia
Tax fingerprint in adult T-cell leukemia
How I treat elderly patients with myeloma
Desferrioxamine-chelatable iron, a component of serum non–transferrin-bound iron, used for assessing chelation therapy by William Breuer, Marieke J. J.
Relationship between urinary TNF-α and RANTES excretion
by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu
Identification of a novel mutation (C321X) in HJV
Fusion genes in cord blood
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients by William J. Hogan,
Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
A Prospective Study of Iron Overload Management in Allogeneic Hematopoietic Cell Transplantation Survivors  Navneet S. Majhail, Hillard M. Lazarus, Linda.
by Rong Chen, Michael J. Keating, Varsha Gandhi, and William Plunkett
by John C. Wood, Pinggao Zhang, Hugh Y
How we choose factor VIII to treat hemophilia
by Alexander Röth, Andreas Hüttmann, Russell P
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator by Yan Jiao, John Wilkinson, Xiumin Di, Wei Wang,
Successful Treatment of Iron Overload by Phlebotomies in a Patient With Severe Congenital Dyserythropoietic Anemia Type II by W.K. Hofmann, J.P. Kaltwasser,
by James D. Cook, Carol H. Flowers, and Barry S. Skikne
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Stage C or not stage C…? by Claire Dearden Blood
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score by Ollivier Legrand, Jean-Yves Perrot, Marion Baudard, Annie.
Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors by Jean-Michel Paulus, Najet Debili, Frédéric Larbret,
by Anita Hill, Peter Hillmen, Stephen J
Navneet S. Majhail, Todd DeFor, Hillard M. Lazarus, Linda J. Burns 
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Volume 54, Issue 2, Pages (August 1998)
by Hideki Yoshioka, Hiromi Sato, Hiroto Hatakeyama, and Akihiro Hisaka
Kamyar Kalantar-Zadeh  Kidney International 
Figure 2. EZO levels in infants and young children compared to adults at similar doses EZO levels in infants and young children compared to adults at similar.
Joseph W. Eschbach, John W. Adamson  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
by Dana T. Lounder, Qiong Bin, Cristina de Min, and Michael B. Jordan
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Iron Overload Manifesting as Apparent Exacerbation of Hepatic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Rammurti.
Volume 66, Issue 3, Pages (September 2004)
Multivariable logistic regression analysis of D-dimer concentrations between study groups. Multivariable logistic regression analysis of D-dimer concentrations.
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Relationships between annual antibiotic purchase rates and progression of microalbuminuria in patients with type 1 diabetes. Relationships between annual.
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
How I treat thrombocytopenia in pregnancy
Adjusted HRs for type 2 diabetes by ferritin, TSAT, serum iron and transferrin levels in men and women. Adjusted HRs for type 2 diabetes by ferritin, TSAT,
Rituximab immunotherapy: it’s getting personal
Time-dependent survival estimation in post–polycythemia vera myelofibrosis. Time-dependent survival estimation in post–polycythemia vera myelofibrosis.
Differentiation of common pediatric brain tumors by quantitative 1H-MR spectroscopy. Differentiation of common pediatric brain tumors by quantitative 1H-MR.
Biochemical profile of idiopathic uric acid nephrolithiasis
Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation  Philippe Armand, Haesook T. Kim, Joanna Rhodes,
Presentation transcript:

Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias by Peter D. Jensen, Finn T. Jensen, Thorkil Christensen, Johan L. Nielsen, and Joergen Ellegaard Blood Volume 101(1):91-96 January 1, 2003 ©2003 by American Society of Hematology

Relationship between aminotransferase serum levels and several indices of iron status in 39 nonthalassemic adult patients with transfusional iron overload.Horizontal lines represent upper reference limit for ALT (40 U/L) and ALT (40 U/L) serum activity. Relationship between aminotransferase serum levels and several indices of iron status in 39 nonthalassemic adult patients with transfusional iron overload.Horizontal lines represent upper reference limit for ALT (40 U/L) and ALT (40 U/L) serum activity. The serum ferritin panels also show regression of ALT and AST to the serum ferritin concentration. For further details, see “Patients, materials, and methods.” Peter D. Jensen et al. Blood 2003;101:91-96 ©2003 by American Society of Hematology

Follow-up data on the ALT and indices of iron status in 12 patients with transfusional iron overload on iron chelation with DFO.Individual patients may be identified within the different panels by use of a single symbol and color for each patient. Follow-up data on the ALT and indices of iron status in 12 patients with transfusional iron overload on iron chelation with DFO.Individual patients may be identified within the different panels by use of a single symbol and color for each patient. Urinary iron excretion was not measured in patients 3 and 12. The horizontal line in panel A represent the upper reference limit for ALT serum activity (40 U/L). Peter D. Jensen et al. Blood 2003;101:91-96 ©2003 by American Society of Hematology

Relationship between ALT and AST and liver iron concentration during iron chelation by lowess regression (tension = 66).Data are obtained from Figure 2, panels A and C, and corresponding AST values (not shown in Figure 2). Relationship between ALT and AST and liver iron concentration during iron chelation by lowess regression (tension = 66).Data are obtained from Figure 2, panels A and C, and corresponding AST values (not shown in Figure 2). The total number of observations is 86 in panel A and 83 in panel B. Horizontal lines represent upper reference limits for ALT and AST (40 U/L). Peter D. Jensen et al. Blood 2003;101:91-96 ©2003 by American Society of Hematology

Relationships between the ALT and indices of iron status and interrelationships during iron chelation by lowess regression (tension = 66).The data are obtained from Figure 2, panels A to D. The total number of observations is 66 in panel A, 68 in panel B, a... Relationships between the ALT and indices of iron status and interrelationships during iron chelation by lowess regression (tension = 66).The data are obtained from Figure 2, panels A to D. The total number of observations is 66 in panel A, 68 in panel B, and 86 in panels C and D. Lines in panels A-B show regression of ALT to the urinary iron excretion and the serum ferritin concentration; lines in panels C-D show regression of urinary iron excretion and serum ferritin concentration to the liver iron concentration. Peter D. Jensen et al. Blood 2003;101:91-96 ©2003 by American Society of Hematology